Edwards Lifesciences Corporation Debt Securities, Held-to-maturity
Edwards Lifesciences Corporation (EW) had Debt Securities, Held-to-maturity of $39.10 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Balance Sheet › Assets › Investments › Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss
us-gaap:HeldToMaturitySecurities · last filed 2026-02-25
- 2025-12-31: Debt Securities, Held-to-maturity $39.10M.
- 2024-12-31: Debt Securities, Held-to-maturity $57.90M.
- 2023-12-31: Debt Securities, Held-to-maturity $64.50M.
- 2022-12-31: Debt Securities, Held-to-maturity $96.00M.
| Period end | Debt Securities, Held-to-maturity |
|---|---|
| 2025-12-31 | $39.10M 10-K · filed 2026-02-25 |
| 2024-12-31 | $57.90M 10-K · filed 2025-02-28 |
| 2023-12-31 | $64.50M 10-K · filed 2024-02-12 |
| 2022-12-31 | $96.00M 10-K · filed 2023-02-13 |
| 2021-12-31 | $162.00M 10-K · filed 2022-02-14 |
| 2020-12-31 | $50.00M 10-K · filed 2021-02-12 |
| 2019-12-31 | $100.20M 10-K · filed 2020-02-14 |
| 2019-03-31 | $30.00M 10-Q · filed 2019-04-26 |
| 2018-12-31 | $20.00M 10-K · filed 2019-02-15 |
| 2018-09-30 | $190.00M 10-Q · filed 2018-10-26 |
| 2018-06-30 | $48.70M 10-Q · filed 2018-07-27 |
| 2018-03-31 | $149.70M 10-Q · filed 2018-04-27 |
| 2017-12-31 | $388.20M 10-K · filed 2019-02-15 |
| 2017-09-30 | $622.00M 10-Q · filed 2017-10-27 |
| 2017-06-30 | $511.80M 10-Q · filed 2017-07-28 |
| 2017-03-31 | $8.60M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $238.30M 10-K · filed 2018-02-16 |
| 2016-09-30 | $447.00M 10-Q · filed 2016-10-28 |
| 2016-06-30 | $604.40M 10-Q · filed 2016-07-29 |
| 2016-03-31 | $398.40M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $495.40M 10-K · filed 2017-02-17 |
| 2015-09-30 | $598.20M 10-Q · filed 2015-10-29 |
| 2015-06-30 | $820.70M 10-Q · filed 2015-07-29 |
| 2015-03-31 | $916.80M 10-Q · filed 2015-04-29 |
| 2014-12-31 | $839.40M 10-K · filed 2016-02-19 |
| 2014-09-30 | $1.19B 10-Q · filed 2014-10-31 |
| 2014-06-30 | $1.07B 10-Q · filed 2014-08-04 |
| 2014-03-31 | $612.00M 10-Q · filed 2014-05-02 |
| 2013-12-31 | $516.50M 10-K · filed 2015-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |